Sort   by:  
 Page size 
UnknownCTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Not available
S-EPMC11560846 | biostudies-literature
UnknownThe Immune Landscape of Cancer.
Not available
S-EPMC5982584 | biostudies-literature
UnknownOncogenic Signaling Pathways in The Cancer Genome Atlas.
Not available
S-EPMC6070353 | biostudies-literature
UnknownClinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.
Not available
S-EPMC4908179 | biostudies-literature
UnknownPerspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Not available
S-EPMC5916814 | biostudies-literature
UnknownAdjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186 | biostudies-literature
UnknownOverall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Not available
S-EPMC10207856 | biostudies-literature
UnknownGlobal age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535839 | biostudies-literature
Sort   by:  
 Page size